NPI: 1790752376 · LARGO, FL 33778 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,479 | $424K |
| 2019 | 13,353 | $2.77M |
| 2020 | 18,823 | $3.08M |
| 2021 | 10,254 | $320K |
| 2022 | 5,786 | $843K |
| 2023 | 2,313 | $358K |
| 2024 | 347 | $17K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,477 | 1,244 | $2.61M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,150 | 686 | $2.60M |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,902 | 459 | $967K |
| A4657 | Syringe, with or without needle, each | 2,097 | 844 | $476K |
| J1756 | Injection, iron sucrose, 1 mg | 2,984 | 563 | $462K |
| 85041 | 1,333 | 795 | $161K | |
| 85048 | 1,328 | 794 | $160K | |
| 83970 | 644 | 388 | $94K | |
| 83540 | 571 | 356 | $69K | |
| 83550 | 571 | 356 | $69K | |
| 82728 | 527 | 330 | $64K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 403 | 129 | $47K |
| 82607 | 122 | 69 | $13K | |
| 82108 | 100 | 52 | $9K | |
| 82746 | 41 | 26 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 58 | 25 | $5K |
| G0008 | Administration of influenza virus vaccine | 24 | 13 | $1K |
| 90674 | 23 | 13 | $1K |